Paper34829454
Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction.
Santoro G and 7 others. Diagnostics (Basel), 2021. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction. Papers, record 34829454. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34829454
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26428496 | MicroRNAs in placental health and disease. | Am J Obstet Gynecol | 2015 | https://conductscience.org/library/papers/26428496 | PubMed |
| 2 | 29361555 | PLAC8, a new marker for human interstitial extravillous trophoblast cells, promotes their invasion and migration. | Development | 2018 | https://conductscience.org/library/papers/29361555 | PubMed |
| 3 | 27503895 | miR-579-3p controls melanoma progression and resistance to target therapy. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27503895 | PubMed |
| 4 | 23059743 | MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. | Br J Cancer | 2012 | https://conductscience.org/library/papers/23059743 | PubMed |
| 5 | 22647363 | The microRNA-17-92 family of microRNA clusters in development and disease. | Cancer J | 2012 | https://conductscience.org/library/papers/22647363 | PubMed |
| 6 | 16032774 | Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. | Prenat Diagn | 2005 | https://conductscience.org/library/papers/16032774 | PubMed |
| 7 | 31213835 | microRNA-612 suppresses the malignant development of non-small-cell lung cancer by directly targeting bromodomain-containing protein 4. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31213835 | PubMed |
| 8 | 31216670 | The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31216670 | PubMed |
| 9 | 30833415 | Maternal circulating miRNAs that predict infant FASD outcomes influence placental maturation. | Life Sci Alliance | 2019 | https://conductscience.org/library/papers/30833415 | PubMed |
| 10 | 30319550 | Regulation of Placental Development and Its Impact on Fetal Growth-New Insights From Mouse Models. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/30319550 | PubMed |
| 11 | 25252010 | Maternal plasma cell-free DNA in the prediction of pre-eclampsia. | Ultrasound Obstet Gynecol | 2015 | https://conductscience.org/library/papers/25252010 | PubMed |
| 12 | 30056492 | Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction. | Mol Diagn Ther | 2018 | https://conductscience.org/library/papers/30056492 | PubMed |
| 13 | 27257136 | Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening. | Prenat Diagn | 2016 | https://conductscience.org/library/papers/27257136 | PubMed |
| 14 | 30413763 | SATB family chromatin organizers as master regulators of tumor progression. | Oncogene | 2019 | https://conductscience.org/library/papers/30413763 | PubMed |
| 15 | 28881030 | The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction. | Prenat Diagn | 2017 | https://conductscience.org/library/papers/28881030 | PubMed |
| 16 | 33785045 | Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies. | BMC Med Genomics | 2021 | https://conductscience.org/library/papers/33785045 | PubMed |
| 17 | 23354729 | Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy. | Prenat Diagn | 2013 | https://conductscience.org/library/papers/23354729 | PubMed |
| 18 | 28880997 | The role of the miR-148/-152 family in physiology and disease. | Eur J Immunol | 2017 | https://conductscience.org/library/papers/28880997 | PubMed |
| 19 | 20980691 | IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor. | Biol Reprod | 2011 | https://conductscience.org/library/papers/20980691 | PubMed |
| 20 | 26781507 | Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. | BMJ Open | 2016 | https://conductscience.org/library/papers/26781507 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38322831 | Identification of differentially expressed miRNAs in plasma exosomes from patients with early-onset pre-eclampsia using next generation sequencing. | Heliyon | 2024 | https://conductscience.org/library/papers/38322831 | PubMed |
| 38164433 | Maternal and Fetal Factors Affecting Cell-Free Fetal DNA (cffDNA) Fraction: A Systematic Review. | J Reprod Infertil | 2023 | https://conductscience.org/library/papers/38164433 | PubMed |
| 36028645 | Epigenetics Beyond Fetal Growth Restriction: A Comprehensive Overview. | Mol Diagn Ther | 2022 | https://conductscience.org/library/papers/36028645 | PubMed |
| 35806250 | LIN28 Family in Testis: Control of Cell Renewal, Maturation, Fertility and Aging. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806250 | PubMed |
Genes174
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34829454
GET https://conductscience.org/api/papers/v1/34829454/references?page=2